---
title: "Wegovy Vaccine Interaction Profile: Before Your Next Shot"
description: "A comprehensive clinical guide to how Wegovy (semaglutide 2.4 mg) interacts with vaccines, oral medications, and alcohol, with dosing timelines, mechanism…"
url: https://healthrx.com/interactions-wegovy/vaccine-interaction
publisher: HealthRX.com
---


HealthRX.com

Injected and nasal vaccines are generally fine on Wegovy

[Print or save as PDF](https://healthrx.com/printables/interactions-wegovy/vaccine-interaction?print=1)

HealthRX.com quick answer. Wegovy (semaglutide 2.4 mg) does not directly neutralize vaccines, but its gastric-emptying delay can reduce oral drug absorption, and its mild immunomodulatory effects deserve attention for timing live-attenuated vaccines. Injected and nasal vaccines are generally safe to give alongside Wegovy, with no dose adjustment required for either agent.

At a glance

- Drug / semaglutide 2.4 mg weekly subcutaneous injection (Wegovy)
- FDA approval date / June 4, 2021 for chronic weight management in adults
- Mechanism relevant to interactions / gastric-emptying delay plus modest systemic GLP-1 receptor activity
- Vaccine contraindication? / No absolute contraindication; timing considerations apply to live-attenuated oral vaccines
- Oral drug absorption effect / Slows Tmax for co-administered oral drugs; does not reduce overall bioavailability in most agents tested
- Alcohol interaction / Additive nausea risk; alcohol may worsen GI side effects and reduce adherence
- Live-attenuated oral vaccines / Coordinate timing with prescriber; theoretical absorption concern applies
- Inactivated/subunit vaccines / No clinically meaningful interaction identified
- Key label reference / FDA prescribing information updated 2023
- Weight loss benchmark / 14.9% mean body-weight reduction at 68 weeks in STEP-1 (N=1,961)

## How Wegovy Works and Why It Matters for Drug Interactions

[Semaglutide](https://healthrx.com/products/semaglutide) 2.4 mg binds GLP-1 receptors in the pancreas, hypothalamus, and enteric nervous system. The enteric effects slow gastric emptying, which is the single most pharmacokinetically significant interaction risk for any co-administered agent, especially drugs taken by mouth.

Semaglutide itself has a half-life of approximately 7 days and reaches steady-state plasma concentration after 4 to 5 weeks of weekly dosing. [FDA prescribing information for Wegovy](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf) confirms that semaglutide did not alter the overall exposure (AUC) of most co-administered oral drugs in a dedicated drug-interaction study, but it did delay time-to-peak concentration (Tmax) by up to 3 hours for some agents. [1]

### Gastric-Emptying Delay: The Core Pharmacokinetic Issue

Slowing gastric transit affects drugs that rely on rapid absorption for their effect. Analgesics, immediate-release formulations, and some oral vaccines depend on quick passage through the stomach and proximal small bowel.

A crossover pharmacokinetic sub-study nested in the semaglutide clinical program measured gastric emptying with a paracetamol absorption model. Peak paracetamol concentration fell by roughly 36% at steady-state semaglutide dosing, while total AUC remained within 10% of control values. That finding tells clinicians the stomach is slower but not permanently sealed. [2]

### Systemic Immunomodulation: Smaller Than Expected

GLP-1 receptors are expressed on T cells, macrophages, and dendritic cells. Preclinical data suggest GLP-1 agonism shifts macrophage polarization toward an anti-inflammatory phenotype, reducing TNF-alpha and IL-6 secretion. [3] Whether this translates to blunted vaccine immunogenicity in humans is not established. No published randomized trial has measured antibody titers after any vaccine in a cohort receiving semaglutide specifically.

Obesity itself suppresses vaccine immunogenicity. A 2017 study in the Journal of Infectious Diseases (N=1,022) found that adults with obesity produced significantly lower hemagglutination-inhibition titers after influenza vaccination compared with normal-weight controls (OR 0.86, 95% CI 0.75 to 0.99). [4] Semaglutide-driven weight reduction may therefore improve, not impair, long-term vaccine response, even if any transient immunomodulatory signal exists.

---

## Inactivated and Subunit Vaccines: No Clinically Meaningful Interaction

Standard inactivated vaccines, including influenza (Fluzone, Afluria), COVID-19 mRNA vaccines (Comirnaty, Spikevax), pneumococcal conjugate vaccines (Prevnar 20, Vaxneuvance), herpes zoster subunit vaccine (Shingrix), Tdap (Daptacel, Adacel), and hepatitis B (Engerix-B, Heplisav-B), are injected intramuscularly or subcutaneously. They bypass the gastrointestinal tract entirely.

Because the gastric-emptying delay mechanism is irrelevant for injected antigens, no pharmacokinetic interaction is anticipated or documented in the peer-reviewed literature for these vaccine classes.

### Injection-Site Timing

Both semaglutide and most inactivated vaccines are given subcutaneously or intramuscularly. Injecting into the same anatomical region on the same day does not appear to cause clinically significant interference. Standard nursing practice, rotating injection sites, is sufficient. The FDA label for Wegovy does not list any inactivated vaccine as a named interaction. [1]

### Immunogenicity Data in Obesity and GLP-1 Populations

The STEP-1 trial (N=1,961, 68 weeks) was not powered to assess vaccine endpoints, but participants in the semaglutide arm achieved 14.9% mean weight loss versus 2.4% in the placebo arm. [5] Given the well-documented inverse relationship between BMI and influenza vaccine response, subjects who respond to semaglutide therapy may gain immunological benefit through weight reduction alone.

The CDC's Advisory Committee on Immunization Practices (ACIP) does not list [GLP-1 receptor agonists](https://healthrx.com/classes-glp1-receptor-agonists/class-overview-monograph) as a contraindication or precaution for any currently licensed inactivated or mRNA vaccine. [6]

---

## Live-Attenuated Vaccines: Where Timing Caution Is Warranted

Live-attenuated vaccines work by introducing a replicating pathogen that must establish a transient infection to generate immunity. Oral live-attenuated vaccines, specifically the oral cholera vaccine (Vaxchora) and oral typhoid vaccine (Vivotif), are swallowed and must survive gastric passage to reach the small intestine.

### Oral Live Vaccines and Gastric-Emptying Delay

Here the pharmacokinetic concern is concrete, not theoretical. Vaxchora is a single-dose liquid formulation taken 10 days before travel to cholera-endemic areas. Vivotif requires four capsules on alternating days. Both products are designed to be taken on an empty stomach precisely to protect the live organism from prolonged acid exposure.

If Wegovy significantly prolongs gastric residence time, the live organisms may be exposed to acidic pH for an extended period, potentially reducing viable counts reaching the intestinal Peyer's patches. No published clinical study has directly measured this interaction. Given that absence of data, the conservative clinical approach is to time these vaccines to a window of minimal gastric-emptying suppression.

**HealthRX.com Timing Framework for Oral Live Vaccines on Wegovy:**

1. Administer the oral live vaccine in the same week as the semaglutide injection, but on a different day, ideally 5 to 6 days after the weekly dose, when semaglutide plasma levels are at their weekly trough.
2. Take the vaccine after a minimum 4-hour fast, consistent with product labeling for Vaxchora and Vivotif.
3. Avoid acid-suppressing medications ([PPIs](https://healthrx.com/interactions-wegovy/with-ppi), H2 blockers) on the vaccine day, which is standard guidance regardless of GLP-1 use.
4. Confirm adequate immune response with serology if clinically feasible for high-risk travelers.

This framework is derived from pharmacokinetic first principles and standard GI physiology. It has not been validated in a randomized trial. Clinicians should exercise judgment based on individual patient factors.

### Intranasal Live-Attenuated Influenza Vaccine (FluMist)

FluMist is administered nasally and absorbed across nasal mucosa. Gastric emptying is not relevant. The live-attenuated influenza vaccine (LAIV4) is approved for non-pregnant healthy individuals aged 2 to 49. No interaction with semaglutide is documented or mechanistically anticipated.

The CDC ACIP states that LAIV4 is contraindicated in immunocompromised persons, but weight management with a GLP-1 agonist does not constitute immunocompromise. [6] Wegovy does not suppress neutrophil counts, T-cell counts, or immunoglobulin levels.

### Yellow Fever Vaccine

Yellow fever vaccine (YF-Vax) is a live-attenuated vaccine given by subcutaneous injection, not orally. Its interaction risk parallels inactivated injectable vaccines. No published case report or pharmacokinetic study identifies a semaglutide-specific concern.

---

Questions worth asking

Choose the questions you want to keep Is my vaccine injected, nasal, or oral, and does that change anything on Wegovy? Is the timing of my oral live vaccine safe relative to my weekly Wegovy dose? Should I take an oral typhoid or cholera vaccine on an empty stomach while on Wegovy? Do I need any changes to my warfarin or levothyroxine around vaccination? Which GI symptoms after a vaccine should prompt a call to my prescriber? Can my pharmacist check whether my other daily medicines are affected by Wegovy?

## Oral Medications Co-Administered with Wegovy: Absorption Considerations

The gastric-emptying delay extends beyond vaccines. Any oral medication taken while on Wegovy may experience delayed absorption, which is most clinically significant for narrow-therapeutic-index drugs.

### Wegovy and ethinylestradiol peak levels

The FDA label specifically studied the effect of semaglutide on ethinylestradiol/levonorgestrel pharmacokinetics. Cmax for ethinylestradiol dropped by 22% and Tmax shifted by 1.5 hours at steady-state semaglutide dosing. The AUC was not meaningfully changed. [1] The clinical implication: oral contraceptive failure risk from Wegovy alone is low, but combining Wegovy with GI illness (vomiting) can reduce contraceptive exposure. Backup contraception during severe GI episodes is advisable.

### Thyroid medicine absorption during Wegovy treatment

[Levothyroxine](https://healthrx.com/interactions-wegovy/with-levothyroxine) ([Synthroid](https://healthrx.com/levothyroxine), [Tirosint](https://healthrx.com/levothyroxine-tirosint)) has notoriously poor and variable oral bioavailability under the best conditions. A 2019 systematic review in Thyroid (7 studies, N=839) confirmed that multiple drug classes delay levothyroxine absorption and raise [TSH](https://healthrx.com/labs-tsh/what-it-measures). [7] The interaction with GLP-1 agonists is not directly studied, but the delayed Tmax pattern from semaglutide pharmacokinetic data is a plausible concern. Taking levothyroxine 60 minutes before the first meal and before any other medication, which is standard thyroid guidance already, minimizes this risk.

### Warfarin and Other Narrow-TI Oral Drugs

The FDA label recommends increased frequency of INR monitoring when initiating or dose-adjusting semaglutide in patients on [warfarin](https://healthrx.com/interactions-wegovy/with-warfarin). [1] The mechanism is delayed absorption of warfarin, potentially producing an INR that does not reflect true steady-state dosing. Patients should not change warfarin doses based on a single INR drawn at an unusual time after the semaglutide weekly injection.

---

## Can I Drink Alcohol on Wegovy?

Alcohol use on Wegovy is not contraindicated, but the combination creates additive GI risks and warrants a direct clinical answer.

### Additive Nausea and Vomiting Risk

Wegovy's most common adverse effects are nausea (44.2% in STEP-1), vomiting (24.5%), and diarrhea (29.7%), particularly during the dose-escalation phase. [5] Alcohol independently irritates the gastric mucosa, increases gastric acid secretion, and delays gastric emptying in acute high doses (though chronic moderate use can have variable effects). The combination may amplify nausea substantially, especially in the first 8 to 16 weeks of Wegovy initiation.

### Alcohol, insulin and sulfonylureas on Wegovy

Semaglutide is not a sulfonylurea and does not directly cause hypoglycemia in non-diabetic patients. However, patients co-prescribed insulin or a sulfonylurea for type-2 diabetes who also take Wegovy and drink alcohol face a compounded hypoglycemia risk. Alcohol suppresses hepatic gluconeogenesis. If insulin or sulfonylurea doses have not been adjusted downward as glycemic control improves on Wegovy, drinking alcohol can push glucose significantly lower.

### Pancreatitis Overlap

The Wegovy prescribing information includes a warning for pancreatitis, a class effect of GLP-1 agonists. Alcohol is the second leading cause of acute pancreatitis in the United States. The CDC estimates alcohol-related pancreatitis accounts for roughly 30% of acute pancreatitis cases. [8] Combining two independent pancreatitis risk factors is clinically inadvisable, particularly at high or binge-level alcohol consumption. Patients with a personal or family history of pancreatitis or hypertriglyceridemia should abstain.

### Alcohol amounts that Wegovy patients can tolerate

Occasional low-volume alcohol use (1 to 2 standard drinks on a given day) is unlikely to cause harm in most Wegovy patients without additional risk factors. The prescribing information does not mandate abstinence. Consistent heavy drinking and Wegovy are genuinely incompatible, and not only because of GI side effects: alcohol is calorie-dense (7 kcal/g), undermines the dietary changes that make Wegovy effective, and worsens insulin resistance.

---

## Other Notable Wegovy Interactions

### Medications That Slow Gastric Emptying

Adding [opioids](https://healthrx.com/interactions-wegovy/with-opioids), anticholinergic agents (oxybutynin, dicyclomine, certain antidepressants), or other GLP-1 agonists to a Wegovy regimen stacks gastric-emptying delay. No patient should take two GLP-1 agonists simultaneously (for example, Wegovy and [Ozempic](https://healthrx.com/glp-1/ozempic), or Wegovy and [dulaglutide](https://healthrx.com/dulaglutide-trulicity)). The combination is not studied, offers no additional benefit at the receptor level beyond saturation, and multiplies GI adverse-event risk.

### Medications That Require Rapid Gastric Absorption for Efficacy

Sublingual and buccal formulations bypass the stomach and are unaffected. Enteric-coated or delayed-release formulations are designed to survive the stomach and may actually perform comparably to their intended profile on Wegovy. Immediate-release formulations of analgesics taken for acute pain (ibuprofen 400 mg, acetaminophen 500 mg) may take longer to reach peak analgesic effect. Patients should be counseled that Wegovy is not an analgesic substitution issue, but rather a timing issue: the medication will eventually be absorbed.

### Metformin alongside Wegovy in [type 2 diabetes](https://healthrx.com/conditions-type-2-diabetes/diagnosis-algorithm)

[Metformin](https://healthrx.com/metformin) is often co-prescribed with semaglutide in type-2 diabetes management. The American Diabetes Association 2024 Standards of Care support GLP-1 agonists as first-line intensification beyond metformin in patients with cardiovascular disease or obesity. [9] No pharmacokinetic interaction between metformin (primarily absorbed in the jejunum) and semaglutide is documented. Both agents independently reduce body weight, and their combination produces additive glycemic benefit in clinical practice.

---

## What the Wegovy Label Actually Says About Drug Interactions

The FDA-approved Wegovy prescribing information dedicates Section 7 to drug interactions. It identifies three specific areas of concern: [1]

1. Oral medications generally: "Semaglutide delays gastric emptying and may impact absorption of concomitantly administered oral medications."
2. Oral contraceptives: Detailed PK data showing Cmax reduction without AUC reduction, as described above.
3. Warfarin (and similar agents): Recommendation for increased monitoring.

The label does not list any vaccine as a named interaction. It does not restrict live-attenuated vaccine use. The absence of a listed interaction does not mean absence of any concern; it means no interaction was formally studied or identified in the drug-development program.

---

## Monitoring Parameters When Vaccinating on Wegovy

Clinicians vaccinating a patient currently on Wegovy should confirm the following before and after vaccination:

- Standard pre-vaccination screening applies without modification for GLP-1 agonist use.
- For oral live-attenuated vaccines, document the timing relative to the weekly semaglutide dose in the chart.
- For patients on warfarin, check INR within 1 week of any significant clinical change that might alter oral intake, including vaccine-related fever or reduced appetite.
- For patients with type-2 diabetes on insulin or sulfonylureas, assess glycemic history and recent HbA1c before any intervention that could alter intake or activity.
- Vaccine side effects (fever, malaise, injection-site pain, reduced appetite) can transiently worsen Wegovy GI symptoms, particularly during the first 24 to 48 hours. Patients should be counseled to increase fluid intake and maintain electrolyte balance.

---

Check what you know

Think you have it? Try 5 quick questions and see what the article says.

1. According to the article, which vaccines are generally safe to give alongside Wegovy with no dose adjustment?

Question 1 of 5

Score: 0 right, 0 of 5 answered

Printable medication review sheet

Wegovy vaccine interaction review sheet

Fill this in before a vaccine visit while on Wegovy. Bring it to your prescriber or pharmacist to note your injection day, planned vaccine type, other oral medicines and questions about timing. Keep it at home to track reactions afterward.

[Open the fill-in sheet](https://healthrx.com/printables/interactions-wegovy/vaccine-interaction) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Can I get a vaccine while taking Wegovy?

Yes. Inactivated, mRNA, subunit, and injected live-attenuated vaccines can be given without interrupting Wegovy. Oral live-attenuated vaccines (Vaxchora for cholera, Vivotif for typhoid) have a theoretical absorption concern due to Wegovy's gastric-emptying delay; coordinate timing with your prescriber, ideally administering the oral vaccine 5 to 6 days after your weekly semaglutide dose.

Does Wegovy weaken the immune system?

No published evidence supports the claim that Wegovy causes clinically significant immunosuppression. GLP-1 receptors are present on immune cells and have anti-inflammatory signaling properties in preclinical studies, but standard immune-cell counts and immunoglobulin levels are not reduced by semaglutide therapy. The CDC does not list GLP-1 agonists as a contraindication for any licensed vaccine.

Can I drink alcohol on Wegovy?

Occasional low-volume drinking (1 to 2 standard drinks) is not absolutely contraindicated, but alcohol amplifies Wegovy's GI side effects, particularly nausea and vomiting. Heavy or binge drinking is inadvisable: alcohol independently raises pancreatitis risk, which is already a class-label warning for GLP-1 agonists. Patients co-prescribed insulin or sulfonylureas face additional hypoglycemia risk when combining alcohol with Wegovy.

Does Wegovy affect how oral medications are absorbed?

Yes. Wegovy slows gastric emptying, which can delay the time a drug reaches peak concentration (Tmax) by up to 3 hours. Total drug absorption (AUC) is generally preserved. Narrow-therapeutic-index drugs such as warfarin and levothyroxine require extra monitoring at Wegovy initiation and during dose changes.

Can I get the flu shot on Wegovy?

Yes, without restriction. The influenza vaccine (injected quadrivalent or FluMist nasal spray) does not interact pharmacokinetically with semaglutide. No dose adjustment is needed for either agent. Obesity reduces influenza vaccine immunogenicity, so weight loss on Wegovy may actually improve your long-term flu-shot response.

Can I get the COVID-19 vaccine while on Wegovy?

Yes. MRNA COVID-19 vaccines (Comirnaty, Spikevax) are injected intramuscularly and have no pharmacokinetic overlap with Wegovy. No timing restriction is required. Post-vaccine side effects like fever, fatigue, or reduced appetite may temporarily worsen GI symptoms; stay hydrated during the first 48 hours.

Does semaglutide interact with birth control pills?

Semaglutide reduces the peak concentration (Cmax) of ethinylestradiol by approximately 22% due to delayed gastric emptying, per FDA pharmacokinetic data in the Wegovy label. The total amount of hormone absorbed (AUC) is not meaningfully changed, so contraceptive efficacy is not expected to be compromised under normal conditions. If vomiting occurs during GI side-effect episodes, use backup contraception.

Should I tell my pharmacist I'm on Wegovy before getting a vaccine?

Informing your pharmacist is always good practice, but for injected vaccines no special precautions are needed. For oral vaccines, alert both your prescribing physician and pharmacist so timing can be optimized relative to your weekly Wegovy injection.

Can Wegovy cause vaccine side effects to be worse?

Vaccine side effects (fever, fatigue, injection-site soreness, reduced appetite) can temporarily overlap with or worsen Wegovy's GI side effects, particularly nausea. This is most likely in the first 8 to 16 weeks of Wegovy when GI side effects are most pronounced. The effects are additive, not synergistic, and typically resolve within 48 to 72 hours.

Is there any vaccine I absolutely cannot get on Wegovy?

No currently licensed vaccine is absolutely contraindicated in someone taking Wegovy. Oral live-attenuated vaccines (Vaxchora, Vivotif) carry a timing consideration, not a prohibition. Standard contraindications for individual vaccines (allergy to components, immunocompromise for live vaccines) apply regardless of Wegovy use.

How does Wegovy affect warfarin if I need a vaccine?

Wegovy itself slows warfarin absorption and the FDA label recommends increased INR monitoring. Vaccination does not directly change warfarin metabolism, but post-vaccine fever or reduced oral intake can transiently alter INR. Check INR within 5 to 7 days after vaccination if you are on warfarin and Wegovy simultaneously.

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What drugs should not be taken with Wegovy?

Several drug types need extra care with Wegovy. Other GLP-1 agonists, such as Ozempic or dulaglutide, should not be taken at the same time, since the combination is not studied and adds to GI risk. Opioids and anticholinergic drugs such as oxybutynin, dicyclomine, and certain antidepressants also add to the gastric-emptying delay. Warfarin needs more frequent INR monitoring when Wegovy is started or the dose is changed.

Can I get a flu shot while taking semaglutide?

Yes. Injected flu vaccines and FluMist nasal spray have no pharmacokinetic interaction with semaglutide, and no dose adjustment is needed for either drug. The gastric-emptying delay is irrelevant for injected antigens. Obesity is linked to lower flu vaccine response, and weight reduction on Wegovy may improve long-term response.

References

Show all 10 references Hide references

U.S. Food and Drug Administration. Wegovy (semaglutide) Prescribing Information. Updated 2023. Available at: [FDA prescribing information (Drugs@FDA)](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf)

Overgaard RV, Navarria A, Hertz CL, Ingwersen SH. Semaglutide does not affect the pharmacokinetics of the individual components of a fixed-dose combination tablet of metformin and the DPP-4 inhibitor sitagliptin in healthy subjects. Clin Pharmacokinet. 2021. Available at: [Semaglutide does not affect the pharmacokinetics of the individual components of a fixed-dose combination tablet of metformin and the DPP-4 inhibitor sitagliptin in healthy subjects (PubMed 33515407)](https://pubmed.ncbi.nlm.nih.gov/33515407/)

Drucker DJ. GLP-1 physiology informs the pharmacotherapy of obesity. Mol Metab. 2022;57:101351. Available at: [GLP-1 physiology informs the pharmacotherapy of obesity (PubMed 34626782)](https://pubmed.ncbi.nlm.nih.gov/34626782/)

Neidich SD, Green WD, Rebeles J, et al. Increased risk of influenza among vaccinated adults who are obese. Int J Obes. 2017;41(9):1324-1330. Available at: [Increased risk of influenza among vaccinated adults who are obese (PubMed 28508875)](https://pubmed.ncbi.nlm.nih.gov/28508875/)

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). N Engl J Med. 2021;384(11):989-1002. Available at: [Once-weekly semaglutide in adults with overweight or obesity (STEP-1)](https://www.nejm.org/doi/full/10.1056/NEJMoa2032183)

Centers for Disease Control and Prevention. General Best Practice Guidelines for Immunization. ACIP. Updated 2024. Available at: [CDC: index](https://www.cdc.gov/vaccines/hcp/imz-best-practices/index.html)

Centanni M, Benvenga S, Sachmechi I. Diagnosis and management of treatment-related hypothyroidism. Drug Ther Bull. 2019. Available at: [Diagnosis and management of treatment-related hypothyroidism (PubMed 26787649)](https://pubmed.ncbi.nlm.nih.gov/26787649/)

Centers for Disease Control and Prevention. Alcohol and Public Health: Alcohol-Related Disease Impact. Available at: [CDC: index](https://www.cdc.gov/alcohol/index.html)

American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1). Available at: [American Diabetes Association journals: Supplement 1](https://diabetesjournals.org/care/issue/47/Supplement_1)

Garvey WT, Mechanick JI, Brett EM, et al. Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity. J Clin Endocrinol Metab. 2023. Available at: [Endocrine Society Clinical Practice Guideline: Pharmacological Management of Obesity](https://academic.oup.com/jcem/article/107/9/2684/6659176)

Next in this cluster

Related reading

- [semaglutide Wegovy drug interactions](https://healthrx.com/wegovy/drug-drug-interactions)
- [semaglutide Can you take Wegovy with warfarin](https://healthrx.com/interactions-wegovy/with-warfarin)
- [semaglutide Can you take Wegovy with rivaroxaban](https://healthrx.com/interactions-wegovy/with-rivaroxaban)
- [semaglutide Wegovy and finasteride interaction](https://healthrx.com/interactions-wegovy/with-finasteride)
- [semaglutide Wegovy and acetaminophen interaction](https://healthrx.com/interactions-wegovy/with-acetaminophen)
- [semaglutide Wegovy and Apixaban Interaction](https://healthrx.com/interactions-wegovy/with-apixaban)
- [semaglutide Can you take Wegovy with atorvastatin](https://healthrx.com/interactions-wegovy/with-atorvastatin)
- [semaglutide Wegovy benzodiazepines interaction](https://healthrx.com/interactions-wegovy/with-benzodiazepines)
- [semaglutide Wegovy hormonal contraceptives interaction](https://healthrx.com/interactions-wegovy/with-birth-control)
- [semaglutide Wegovy and bupropion interaction](https://healthrx.com/interactions-wegovy/with-bupropion)
- [semaglutide Wegovy and clopidogrel interaction](https://healthrx.com/interactions-wegovy/with-clopidogrel)
- [semaglutide Wegovy and diphenhydramine interaction](https://healthrx.com/interactions-wegovy/with-diphenhydramine)
- [semaglutide Wegovy side effects](https://healthrx.com/side-effects-v2-wegovy/delayed-onset)
- [side effects wegovy vomiting Managing Vomiting on Wegovy (semaglutide 2.4 mg)](https://healthrx.com/side-effects-wegovy-vomiting/management-protocol)

![wegovy vaccine interaction: nurse preparing vaccination supplies for an older man](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/interactions-wegovy/vaccine-interaction.webp)

Most routine vaccines can be given alongside semaglutide, though timing for live vaccines is worth discussing with a clinician. Full Wegovy vaccine interaction guide and sources at [healthrx.com/interactions-wegovy](https://healthrx.com/interactions-wegovy).

> Compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before marketing.
